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Abstract
Background: The literature findings report that use of multiple substances can produce adverse clinical and behavioral effects, which may affect craving and 
the results of drug treatment. Also, the understanding of craving construct and its interaction in the use of smoked substances is underexplored. Objectives: 
To induce and compare craving for tobacco, marijuana and crack-cocaine on hospitalized dependents whose drug of choice is crack-cocaine. Methods: Quasi-
-experimental study with a convenience sample consisting of 210 males divided into 3 equal groups (Group-1: craving induced by crack; Group-2: craving 
induced by tobacco; and Group-3: craving induced by marijuana). All participants met ICD-10 dependence criteria for cocaine/crack, marijuana and tobacco, 
were aged between 18 and 65 and had used these substances for at least one year. Photos were used to induce craving and self-report instruments to evaluate 
possible alterations. Results: This study showed that craving for tobacco was more intense than for marijuana and crack, when the groups were compared 
by VAS. Using specific scales, both craving for tobacco and craving for marijuana were more intense than craving for crack. Discussion: These results would 
imply interventions at the initial stages of abstinence with cognitive-behavioural techniques and pharmacotherapy in order to reduce craving.
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Craving is an important concept in the area of drug dependence and 
has been discussed for more than a century; Merck’s Manual of the 
Materia Medica1,2 had, in 1899, already proposed that cocaine be used 
to relieve craving for alcohol, demonstrating one of the first attempts 
to “medicate” craving. In 1954, at a meeting of experts from the World 
Health Organization3, Jellineck, among others, concluded that the 
term “craving” was scientifically inaccurate, as it referred only to an 
urgent and intense desire. The group therefore decided to replace 
“craving” for physical dependence – in cases of craving related to 
withdrawal symptoms – and pathological desire – in cases of desire 
occurring after a longer period of abstinence4. Isbell5 emphasized 
that craving was very difficult to define as it could mean different 
things to different people.
Currently, different concepts of craving can be verified. These 
range from the best known “intense desire to consume a particular 
substance”6 to one that encompasses not only the desire but also “the 
expectation of a positive effect, the relief of withdrawal symptoms 
and negative affect and the intention to use the drug”7. Rankin et al.8 
argued that craving is a multi-dimensional construction and must 
therefore involve physiological, psychological and behavioural aspects.
Despite the importance of this issue, there is little research ana-
lysing and comparing craving for psychoactive substances. Tiffany et 
al.9 considered, for example, that craving for cocaine was related to a 
different area than that experienced by tobacco7: the lack of control; 
however no research was conducted to prove this difference. On the 
other hand some studies have demonstrated evidence that craving 
for tobacco and smoked cocaine (crack) are associated10 and that 
exposure to nicotine can increase cocaine self-administration11 as 
well as trigger its craving, especially among crack users12.
Regarding craving for marijuana, on one hand, one study13 
verified that 93% of marijuana dependents reported only a mild 
craving for the substance whereas, another research14 observed that 
dependents reported a more intense craving than cocaine dependents. 
Budney et al.15 when comparing craving for marijuana and tobacco, 
found that craving for tobacco was slightly more intense.
The literature findings report that cocaine/crack dependents have 
a history of other psychoactive substances use10 and that such use of 
multiple drugs can produce adverse clinical and behavioural effects, 
cumulative and synergistic, via interaction between the substances, 
which may affect craving and the results of drug treatment16. Because 
of the need to better understand the craving construct and its interac-
tion in the use of smoked substances, the purpose of this article is 
to induce and compare craving for tobacco, marijuana and cocaine 
(crack) on hospitalized dependents whose drug of choice is crack.
Methods
Design
This is a quasi-experimental study.
Participants
The subjects were chosen “by convenience” which is defined17 as a 
means of selecting data on which there is a no statistical random-
ness but a value judgment, for example, subjects’ accessibility as 
a criterion. The sample consisted of 210 male subjects, admitted 
to the specialized chemical dependency unit of the São Pedro 
Psychiatric Hospital (Porto Alegre – RS), divided into 3 groups 
each comprising 70 subjects. Group 1 (induced craving for crack), 
group 2 (induced craving for tobacco) and group 3 (induced cra-
ving for marijuana).
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Inclusion criteria
Fulfil ICD-1018 dependence criteria for cocaine/crack, marijuana 
and tobacco. Been using these substances for at least one year, with a 
minimum education level of fifth-grade elementary school and aged 
between 18 and 65 years old. Participants must have been abstinent 
for a period of 7-21 days. All were undergoing Nicotine Replacement 
Therapy (transdermal 21 mg) – which is part of the inpatient unit 
treatment protocol – and were using psychiatric medication. The 
inclusion of the subject in the study was only done if cocaine/crack 
was their “drug of choice” (favourite), since it is difficult to observe 
cocaine/crack dependents that do not use other substances. This 
criterion had already been used in previous studies9,19.
Exclusion criteria
Presenting psychotic symptoms, acute symptoms of mood disorder 
(assessed by the SRQ-20; Mari & Williams, 1986), being dependent on 
other substances or having cognitive impairments that altered perfor-
mance in the tests according to the Mini-Mental State Examination20.
Instruments
Demographics and substance use
Form with socio-demographic data and information related to pat-
tern of psychotropic substance consumption.
Cognitive level
Mini-Mental State Examination (MMSE)20 – screening test to assess 
cognitive level at the time of the interview. 25/30 points suggests 
commitment, and < 20 points indicates, with certainty, that there is 
cognitive impairment21. For this research a cut-off point below 25 
points was used to exclude patients with cognitive impairment from 
the sample group.
Presence of psychotic symptoms
SRQ-20 – A scale previously validated in Brazil22, which screened the 
general population and classified adults either as neurotic (> 7), who 
could participate in the study, or psychotic (> 1), who were excluded.
Severity of dependence
Severity of Tobacco, Cocaine/Crack and Marijuana dependence – as 
there are no validated instruments to assess the severity of depen-
dence on Cocaine/Crack and Marijuana, only on tobacco, in order to 
standardize the assessment of the severity in all groups, their weekly 
consumption was taken as a parameter.
Anxiety symptoms
Beck Anxiety Inventory (BAI)23: this is a scale that measures the se-
verity of anxiety symptoms. It consists of 21 questions in which the 
subject must grade on a four point scale. The total score is obtained 
by summing the individual scores of each question. The cut-offs for 
psychiatric patients, according to the norms of the Portuguese version, 
are: 0-10 = minimal, 11-19 = mild, 20-30 = moderate and 31-63 = 
severe24. This will be administered to the three groups of participants.
Depression symptoms
Beck Depression Inventory (BDI)25: is designed for measuring the 
severity of depression, both in psychiatric patients and in the general 
population. It consists of 21 multiple-choice questions, each with four 
alternatives; the subject must choose the most applicable feeling at 
that moment. The total score is the sum of the points. The cut-offs for 
psychiatric patients were published in 2001 along with the Portuguese 
version by Cunha: 0-11 = minimal 12-19 = mild, 20-35 = moderate 
and 36-63 = severe24.
Craving intensity
Visual Analogue Scale (VAS) – to assess craving this will be admin-
istered to all three groups, the individual will be asked to give their 
craving a grade, where 0 (zero) is the minimum grade (has no crav-
ing) and 10 the maximum (presents a very strong craving), this value 
is marked on a 10 cm scale. Several authors have used the Visual 
Analogue Scale to assess craving in their research26-29.
Cocaine craving
Cocaine Craving Questionnaire Brief (CCQ-Brief)19: 10 scale state-
ments compiled from the 45 statements Cocaine Craving Question-
naire – Now9. The CCQ-Brief is a Likert 7-point scale ranging from 
“strongly disagree” to “strongly agree”. The CCQ-Brief and its version 
adapted for crack were validated in Brazil30-31. The score of the CCQ-
Brief – Adapted Brazilian version for Crack is obtained from the total 
sum of the points (with the statements 4 and 7 reversed should be added 
to the other); from Factor 1 (points) – on the craving itself (the sum of 
all issues except 4 and 7) and Factor 2 – associated with lack of control 
of crack use (sum of questions 4 and 7 inverted). The cut-offs in the 
Brazilian version, for the total scale points, are: 0-11 points, minimum 
craving; 12 to 16, mild; 17-22, moderate; and 23 or more points, intense 
craving. This questionnaire will only be applied to Group 1.
Tobacco craving
Questionnaire of Smoking Urges Brief – Brazilian Version – QSU-B32 
– is an abbreviated scale developed by Cox et al.33 from the Question-
naire of Smoking Urges (QSU)7 used to assess craving for tobacco. 
It is comprised of 10 affirmative statements, to which the individual 
must state their position using a Likert 7-point scale ranging from 
“strongly disagree ‘to’ strongly agree”. The QSU-B in its Brazilian vali-
dation32 can be analysed by the sum total of points and by the points 
of factor 1 related to craving for the positive reinforcing properties of 
tobacco (statements 1, 3, 7 and 10) and by factor 2 related to craving of 
the negative reinforcing properties of this substance (statements 4, 8 
and 9). The cut-offs in the Brazilian version for the scale points total 
are: 0-13 points, minimum craving; 14-26, light; 27-42, moderate; 
and 43 or more points, intense craving. This questionnaire will only 
be applied to Group 2.
Marijuana craving
Marijuana Craving Questionnaire – Short Form – MCQ-SF34 – It is 
a self-reporting scale of 12 items, using Likert 7 points ranging from 
“strongly disagree” to “strongly agree”. It is an abbreviated version of 
the MCQ35, a multidimensional scale of 47 items. In Brazil, the se-
mantic validation was made by Pedroso et al.36. In his psychometric37 
the MCQ-SF was divided into three factors: Emotionality (questions 
1, 9 and 11), Intentionality (questions 3 and 10) and Compulsivity 
(questions 2 and 7) and may be analysed in addition to the method 
of the points in each factor by the sum of the total points (of 12 
questions). The cut-off points in the Brazilian version for the total 
of the scale points are: 0-23 points, minimum craving; 24-38, light; 
39-53, moderate; and 54 or more points, intense craving. This will 
only be applied to Group 3.
Materials to induce craving
¼ A4 size images of marijuana, crack cocaine and tobacco. Before 
being employed in this research the photos were considered faithful 
substance representations, with the potential to elicit craving, by a 
group of 20 hospitalized patients.
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Ethical aspects
Data collection was only initiated after the research project had 
been approved by the Research Ethics Board of São Pedro Psychi-
atric Hospital. Before participants were accepted to be part of the 
research project its purpose was explained to them and they were 
provided with a written informed consent, which was read with the 
individual and any possible doubts clarified. The signing of this form 
was a precondition for the participant to be included in the sample. 
This research was also conducted in accordance with the Helsinki 
Declaration as revised 1989.
Procedures for data collection
Each participant who fulfilled the inclusion criteria was sent individu-
ally to a room where an assessment interview was conducted and a 
record containing socio-demographic data and pattern of psychoac-
tive substance consumption was completed. The SRQ-20, on how they 
felt at that moment was administered its diagnosis evaluated using 
ICD-10. During the experimental study, we recorded the period of 
abstinence from the last crack, tobacco or marijuana consumption, 
which determined whether the participant would be part of Group 1, 
2 or 3 (if evaluated to be part of the marijuana group they would go 
there, if possible, if not they would go to another group with priority 
given to the group with less participants).
After deciding into which group the participant would be 
placed, they were individually shown, for 3 minutes, a photo of the 
desired craving (crack, tobacco or marijuana) related to their group 
after which other evaluation instruments were administered in the 
following order: CCQ-Brief (only for patients in Group 1), QSU-B 
(only for patients in Group 2), MCQ-SF (only for patients in Group 3), 
VAS, BAI and BDI (for all groups).
Data analysis
The data collected was processed in the SPSS statistics software 
(v.20; SPSS Inc., Chicago, IL). Exploratory data analysis consisted 
of descriptive and frequency statistical tests. The inferential analysis 
employed the tests: Chi-squared and Analysis of Variance (ANOVA) 
with Tukey’s test. As the QSU-B and CCQ-Brief scales have ten state-
ments each but the MCQ-SF has twelve, the following calculation: 
“Total points MCQ-SF/12 x 10” was used to allow different substance 
craving results to be compared. The result of this calculation and the 
raw scores of the QSU-B and CCQ-Brief will be presented in table 1. 
The significance level used as a parameter was 5%.
Results
Each of the three groups was composed of 70 participants, regarding 
marital status, in accordance with the chi-squared test, there was no 
significant difference between groups (χ2 = 8.217; p = 0.223), with a 
prevalence of singles: 74.3% (n = 52) in the Crack Group, 80.0% (n = 
56) in the Marijuana Group and 67.1% (n = 47) in the Tobacco Group. 
Group comparison regarding other socio-demographic variables, 
patterns of substance use and symptoms of depression and anxiety 
can be seen in table 2.
The comparison of craving in the three groups via the Visual 
Analogical Scale and other Scales to assess craving (CCQ-Brief, 
QSU-B and MCQ-SF), can be seen in table 1. In both tables, ANOVA 
with Tukey’s test was used. 
Table 3 shows the severity of craving according to the analysis 
of the total of points from the scales and according to the points of 
its factors considering its cut-offs, which were published in their 
respective psychometric validation. 
Discussion
When analysing the results of this study, it was observed that the mari-
juana group was younger, had first begun by using alcohol (earlier than 
the tobacco group), had used crack and inhaled cocaine (earlier than 
the other two groups) and had spent less time without using inhaled 
cocaine (compared to the tobacco group) and without using mari-
juana (than either of the other two groups). In addition, they used an 
extreme amount of marijuana (about 30 joints per week), independent 
of this variable there didn’t appear a significant difference in the three 
groups. Such findings may be due to the convenience sample since 
most patients stopped using marijuana for a period greater than 21 
days and before hospital admission (an inclusion criteria). Those who 
remain using marijuana seem to have a more serious drug use profile, 
which may have interfered with the craving. This result associated 
with the interruption of marijuana use, well before hospitalization, 
had already been highlighted in previous studies38,39 while researching 
crack addicts hospitalized for detoxification.
The Tobacco group was hospitalized for some time, but this dif-
ference did not affect the results, since the controlled variable was 
time in abstinence and not length of hospitalization and, the tendency 
of smokers to continue using tobacco. The Crack group used higher 
amounts of inhaled cocaine than the tobacco group, however, patients 
tended to be abstinent from this form of cocaine use during hospi-
talization, which cannot be taken as an intervening variable when 
comparing craving in the three groups. The interruption of inhaled 
cocaine when given crack was discussed by Balbinot and Araujo38.
The abstinent period of marijuana, however, may have affected 
the intensity of craving, but this variable cannot be controlled because 
of the characteristic of the sample, who had – as observed in other 
studies38,39 – a longer period abstinent from marijuana. However, 
the association between the length of abstinence of marijuana and 
craving was not found in a previous study37.
There was no significant difference in the three groups for symp-
toms of depression and anxiety, mental states that could have inter-
fered with craving, as already highlighted in other studies7,31-32,40-42.
When comparing craving using the Visual Analogue Scale, the 
tobacco group demonstrated a more intense craving than the other 
groups; however when the specific assessing scales for craving were 
used, the tobacco and marijuana groups had a more intense craving 
than the crack group. That the craving result for marijuana is more 
intense than for crack resembles the one found by McRae et al.14, 
however, with respect to inhaled cocaine it contrasts with another 
study13 which didn’t find an intense craving for marijuana.
The more intense tobacco craving, than that for other substances, 
might be associated with the fact that many patients – contrary 
to what occurs with crack – are not motivated to stop using this 
substance, this association had already been emphasized43. Haller et 
al.44 also observed this phenomenon while researching the motiva-
tion for change in female smokers, however, it should be noted that 
other studies found no correlation between craving and motivation 
for change in smokers32,40, which means this would be just one of the 
aspects to explain this finding, since dependence, abstinence and all 
corresponding phenomena with craving have multifactorial etiology.
Analysing craving for the three substances from their sub-factors, 
adding the rates of moderate and severe degrees, it can be observed 
that factor 2 of craving for crack (which refers to uncontrolled crack 
use), the emotionality factor craving for marijuana and factor 2 
(negative reinforcing capacity) the craving for tobacco had higher 
scores. These results demonstrate that craving associated with the use 
of the substance for the relief of negative affect (such as anxiety and 
depression) or withdrawal symptoms was more intense than that for 
obtaining pleasure (positive reinforcement). The relevance, in this 
sample, of emotional aspects and negative reinforcing potential of 
substances to induce craving had already been verified in research 
concerning the craving for tobacco7,43, and marijuana37.
Limitations of this study are related to their possible interference 
with craving. They are: the large average amount of marijuana used 
by the three groups, the length of marijuana abstinence (which is 
higher in the marijuana group), the fact that psychiatric medica-
tion was not controlled45 and the motivation to change addictive 
behaviour not being assessed; which mainly may have affected the 
tobacco craving values43,44, which most patients did not intend to 
stop after hospitalization.
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Table 2. Sample characteristics regarding sociodemographic variables, pattern of use of substances and symptoms of depression and anxiety
Variable
Total Sample Group 1 – Crack Group 2 – Marijuana Group 3 – Tobacco
ANOVA
(n = 210) (n = 70) (n = 70) (n = 70)
M (SD) Min Max M (SD) Min Max M (SD) Min Max M (SD) Min Max F p-value
Age 28.02 (7.41) 18 50 29.35 (6.82)a 18 49 25.89 (7.26)b 18 50 28.89 (7.73)a 18 48 4.671 0.010
Years of Education 7.93 (2.37) 5 15 7.96 (2.28) 5 14 8.14 (2.61) 5 15 7.70 (2.37) 5 15 0.621 0.538
Days of hospitalization 8.68 (3.92) 2 30 8.04 (3.79)a 2 30 8.33 (3.74)a 2 20 9.64 (4.08)b 2 27 3.345 0.037
Age at first use of crack 21.39 (6.39) 10 48 22.94 (6.58)a 10 48 19.15 (5.31)b 12 35 22.09 (6.65)a 13 45 6.864 0.001
Amount of crack use (in 
rocks)/week
23.02 (27.37) 1 168 24.97 (30.66) 1 168 25.03 (28.10) 2 140 19.04 (22.67) 1 112 1.060 0.348
Last use of crack (days) 55.87 (303.96) 1 3600 9.54 (3.79) 7 21 38.58 (129.45) 1 780 138.54 (555.58) 4 3600 2.639 0.074
Age at first cocaine use 16.75 (3.08) 10 35 17.05 (2.41)a 13 25 15.73 (2.42)b 10 25 17.42 (3.94)a 11 35 5.236 0.006
Amount of cocaine 
grams/week
11.67 (20.12) 0 140 17.60 (24.97)a 0 100 9.74 (20.23)ab 0 140 7.80 (12.05)b 0 70 3.953 0.021
Last use of cocaine/
days
576.14 
(1208.89)
2 7300 631.09 
(1078.60)ab
2 5040 277 (759.21)b 6 5400 912.49 (1667.36)a 10 7300 3.400 0.036
Age at first use of 
marijuana
15.06 (3.05) 9 30 15.46 (3.51) 10 30 14.41 (2.54) 9 20 15.34 (2.98) 9 24 2.452 0.089
Amount of marijuana 
cigarette/week
24.35 (28.71) 1 160 22.59 (23.67) 1 140 30.07 (35.03) 2 160 19.86 (24.67) 1 140 2.365 0.097
Last use of marijuana 
(days)
357.21 
(1040.44)
1 6480 506.32 
(1121.44)a
2 5040 10 (3.89)b 7 21 732.27 (1508.07)a 1 6480 7.822 0.001
Age at first tobacco use 13.82 (3.43) 5 36 13.83 (3.04) 5 20 13.22 (2.80) 7 20 14.39 (4.19) 7 36 1.985 0.140
Amount of tobacco 
cigarettes/week
167.41 
(103.11)
5 700 144.98 (70.65) 20 280 181.88 
(127.07)
5 700 173.86 (100.10) 5 560 2.351 0.098
Last use of tobacco 
(days)
8.64 (3.49) 0 20 8.31 (3.20) 2 15 8.73 (4.01) 0 20 8.84 (3.12) 7 16 0.343 0.710
Age at first alcohol use 13.58 (3.24) 4 25 13.62 (2.98)ab 4 20 12.84 (3.52)a 5 25 14.26 (3.10)b 6 25 3.158 0.045
Units of alcohol* use/
week
63.66 (100.82) 0.80 560 63.17 (94.59) 1 373 61.82 (96.37) 1 560 65.89 (111.52) 0.80 560 0.026 0.974
Last use of alcohol 
(days)
89.22 (355.85) 1 4015 88.10 (241.96) 2 1440 40.03 (100.11) 1 540 155.67 (596.31) 5 4015 1.392 0.252
BDI total 15.93 (11.10) 0 55 14.23 (8.83) 0 37 17.82 (12.48) 0 55 15.69 (11.47) 0 52 1.898 0.152
BAI total 10.95 (10.43) 0 48 9.70 (9.79) 0 44 11.54 (10.96) 0 47 11.59 (10.51) 0 48 0.743 0.477
M: means; SD: standard deviation; Min: minimum; Max: maximum; * Unit of alcohol: 10 grams of alcohol; a. b: means significant differences according to the Tukey’s test; F: F-ratio test.
Table 1. Comparison of the averages in the three groups of scores on the craving scales
Variable Total Sample Group 1 – Crack Group 2 – Marijuana Group 3 – Tobacco ANOVA
M (SD) Min Max M (SD) Min Max M (SD) Min Max M (SD) Min Max F p-value
Craving according to 
Visual Analogic Scale
3.41 (3.39) 0 10 2.39 (2.82)a 0 10 3.15 (2.27)a 0 10 4.71 (3.64)b 0 10 9.287 < 0.001
Craving according to 
specifics scales for each 
group
28.60 (17.31) 10 70 19.68 (11.49)a 10 55 32.26 (15.86)b 10 64.17 33.70 (20.12)b 10 70 16.683 < 0.001
M: means; SD: standard deviation; Min: minimum; Max: maximum; a. b: means significant differences according to the Tukey’s test; F: F-ratio test.
Table 3. Levels of craving for crack, marijuana and tobacco
Variable
Craving levels
Minimum Mild Moderate Severe
n % n % n % n %
CCQ-Brief Total 23 32.9 14 20 15 21.4 18 25.7
Craving 0 0 38 54.3 6 8.6 26 37.1
Lack of control 27 38.6 5 7.1 4 5.7 34 48.6
MCQ-SF Total 22 31.4 13 18.6 21 30 14 20
Emotionality 15 21.4 19 27.1 18 25.7 18 25.7
Compulsivity 0 0 50 71.4 6 8.6 14 20
Intentionality 0 0 50 71.4 7 10 13 18.6
QSU-B Total 14 20 17 24.3 15 21.4 24 34.3
Craving positive reinforcing 16 22.9 18 25.7 12 17.1 24 34.3
Craving negative reinforcing 0 0 23 32.9 23 32.9 24 34.3
CCQ-Brief: Cocaine Craving Questionnaire-Brief; MCQ-SF: Marijuana Craving Questionnaire-Short Form; QSU-B: Questionnaire of Smoking Urges-Brief.
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Crack, marijuana and tobacco dependent patients have proven 
to have a more intense craving for tobacco measured by generic scale 
(Visual Analogue Scale), and for tobacco and marijuana measured 
by specific scales. Craving has been associated with relief of negative 
emotional symptoms (such as anxiety and depression). Thus, taking 
into account the patient’s suffering in the initial phase of treatment 
– acute period of abstinence – and the high rates of emotional epi-
sodes, it is important to link the cognitive-behavioural techniques 
with pharmacotherapy to relieve craving.
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